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Abstract
Background: Cigarette smoke exposure during prenatal and early postnatal periods increases the incidence of a variety of
abnormal behaviors later in life. The purpose of this study was to identify the possible critical period of susceptibility to
cigarette smoke exposure and evaluate the possibe effects of cigarette smoke during early life on brain-derived neurotrophic
factor/neurotrophic tyrosine kinase receptor B signaling in the brain.
Methods: Three different age of imprinting control region mice were exposed to cigarette smoke or filtered air for 10 consecutive
days beginning on either gestational day 7 by maternal exposure, or postnatal days 2 or 21 by direct inhalation. A series of behavioral
profiles and neurotrophins in brain were measured 24 hours after mice received acute restraint stress for 1 hour on postnatal day 59.
Results: Cigarette smoke exposure in gestational day 7 and postnatal day 2 produced depression-like behaviors as evidenced
by significantly increased immobility in both tail suspension and forced-swim test. Increased entry latencies, but not
ambulation in the open field test, were also observed in the gestational day 7 and postnatal day 2 cigarette smoke exposure
groups. Genetic analysis showed that gestational day 7 cigarette smoke exposure significantly altered mRNA level of brainderived neurotrophic factor/tyrosine kinase receptor B in the hippocampus. However, behavioral profiles and brain-derived
neurotrophic factor/tyrosine kinase receptor B signaling were not significantly changed in PND21 cigarette smoke exposure
group compared with FA group.
Conclusions: These results suggest that a critical period of susceptibility to cigarette smoke exposure exists in the prenatal
and early postnatal period, which results a downregulation in brain-derived neurotrophic factor/tyrosine kinase receptor B
signaling in the hippocampus and enhances depression-like behaviors later in life.
Keywords: Brain-derived neurotrophic factor, tropomyosin receptor kinase B, pregnancy smoking.

Introduction
Cigarette smoking is common among pregnant women (Allen
et al., 2008; T. Liu et al., 2011; Cornelius et al., 2012; Elmasry et al.,
2014). Ten to fifteen percent of pregnant women continue smoking despite multiple adverse outcomes in offspring (Mendola

et al., 2002; Cornelius et al., 2011; Amos-Kroohs et al., 2013).
Maternal smoking during pregnancy has been reported associated with abnormal behaviors and cognitive development in offspring, and these adverse effects on neurodevelopment might
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Met may moderate depression or anxiety from smoking (Jamal
et al., 2015a). Thus, we hypothesized that susceptibility to CS
exposure exists during prenatal and early postnatal periods and
that CS exposure during these “critical periods” may alter BDNF/
TrkB signaling and induce depression-like behaviors in later life.
The present experiments are designed to identify critical developmental periods of susceptibility to CS exposure in mice and
characterize changes in behaviors and neurotrophins expression during these critical periods to determine the possible
underlying mechanisms.

Methods
All procedures were performed in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals
8th edition, published by the National Institutes of Health in 2011,
and the protocols were approved by the local Animal Care and
Use Committee.
The central nervous system is not fully developed during
prenatal life, and the structural and functional development
continues until postnatal days (PND) 14 to 21 days (Arnold and
Trojanowski, 1996; Grove and Tole, 1999; Tole and Grove, 2001).
The effects of CS exposure were investigated in 3 different ages
of imprinting control region (ICR) mice: gestational day (GD) 7 to
GD 16, which corresponds to the period of human fetal development; PND 2 to PND 11, which corresponds to the human neonatal period; and PND 21 to PND 30, which is similar to the human
prepubertal time period (Pinkerton and Joad, 2000). The previous
studies have shown that CS exposure for 6 h/d for a few weeks
to 2 months alters pulmonary function, immune responses, and
brain neurons in monkey, rat, and mouse models (Barrett et al.,
2002; Yu et al., 2008; Wu et al., 2012). Three different age of mice
were exposed to either CS or filtered air (FA) for 6 h/d for 10 consecutive days beginning on GD7 (by maternal exposure), PND2,
or PND21 (direct exposure) (Figure 1). The 10-day exposure periods were chosen to allow testing of our experimental design in
nonoverlapping developmental time periods. In addition, mice
at 2 weeks of age are nearing maturity; thus, exposure in the
PND2 group was completed before maturity, and exposure in
the PND21 began after maturity. During the exposure period,
dams and infants lived in the same cage with access to food
and water. For the GD7 group, exposure initiated 10 days prior
to the approximate date of parturition during the period when
the central nervous system is beginning to form. After exposure,
mice were housed with access to food and water ad libitum in
an FDA-approved facility.
The level of cotinine in blood was measured at the end of the
daily CS exposure on GD 7, GD 10, and GD 15 in the GD7 group
from dams, on PND 3, PND 6, and PND 10 in the PND2 group from
pups, and on PND 22, PND 25, and PND 29 in the PND21 group
from exposed mice by cotinine Elisa Kit (Sigma, St. Louis, MO).
All groups of mice received acute restraint stress (ARS) for 1
hour on PND59 and then were challenged with behavioral tests
24 hours later. After behavioral tests, mice were sacrificed by
decapitation. The hippocampus and prefrontal cortex were dissected and immediately frozen on dry ice and kept at -80°C for
PCR array, Western blotting, and ELISA test. The intent of this
design was to examine the effects of CS on behaviors and potential mechanisms associated with early-life exposure by comparing responsiveness to CS after a period of recovery in naive
mice and mice exposed to CS at 3 stages of life. ARS for 1 hour
could not decrease exploration in the open arm of elevated plusmaze (Vargas-Lopez et al., 2015). In our preliminary experiment,
we also found that ARS in our stress model for 1 hour did not
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persist through adolescent period and extend into adulthood
(Weitzman et al., 1992; Barros et al., 2011; Cornelius et al., 2011;
T. Liu et al., 2011; Cornelius et al., 2012; Elmasry et al., 2014). The
probability of developing psychiatric disorders increases in children whose mothers smoke cigarettes during pregnancy, suggesting a possible critical period of developmental sensitivity
to cigarette smoke (CS) exposure exists during the prenatal and
early postnatal period.
The central nervous system develops rapidly during fetal and
early postnatal life. Given the dynamic and vulnerable nature of
developmental processes, this period of morphogenesis is likely
to be exquisitely sensitive to environmental insults (Slotkin et al.,
2002; Dwyer et al., 2009; La Maestra et al., 2011; Amos-Kroohs
et al., 2013; Balsevich et al., 2014). Although little is known about
how prenatal and early postnatal smoking exposure influences
brain development, emerging studies have shown that neurotransmitters are changed in nicotine and cigarette smoking animals (Slotkin et al., 2002, 2006; Parameshwaran et al., 2012). In
animal models, decreased brain weight, cortical thickness, and
neural density were found in prenatal CS-exposed groups (Roy
and Sabherwal, 1994). Similarly, clinical studies have also shown
that prenatal CS exposure resulted in a reduction in fetal head
growth and cerebellar development (Roza et al., 2007; Rivkin
et al., 2008; Ekblad et al., 2010; El Marroun et al., 2014). The imaging studies further found the decreased frontal lobe, frontal
cortex, and parahippocampal cortices in neonates with CS exposure (Ekblad et al., 2010; Haghighi et al., 2013; J. Liu et al., 2013). In
addition, reduced cerebral cortical gray matter and cortical gray
matter, including amygdala and thalamus in CS-exposed children, were also found (Rivkin et al., 2008). Although these studies have demonstrated prenatal CS exposure correlates with
abnormal brain function and morphology, the signaling cascade
underlying these alterations still remains unclear.
Neurotrophins, a group of polypeptide growth factors,
includes nerve growth factor, brain-derived neurotrophic factor (BDNF), neurotrophin-3, and neurotrophin-4 (Huang and
Reichardt, 2001). BDNF is the most important neurotrophic factor that promotes and maintains growth and survival of the
central nervous system (McAllister, 2001; Soule et al., 2006;
Cowansage et al., 2010; Gomez-Palacio-Schjetnan and Escobar,
2013). The function of BDNF is mainly mediated by binding to
its receptors, such as tropomycin receptor kinase (TrkB) family
of tyrosine kinase receptors (Lu et al., 2005; B. H. Lee and Kim,
2010). Disruption of normal synthesis and release of BDNF has
been reported to associate with a variety of behavioral abnormalities (Nibuya et al., 1995; Tang et al., 2008; Tuon et al., 2010;
Yochum et al., 2014). Compromised function of plasticity and
BDNF signaling has been implied in the pathophysiology of
depression. Duman and coworkers (1997) have shown that
synthesis of BDNF was increased by antidepressant treatment,
suggesting a deficiency in BDNF might contribute to depressionlike behaviors (Duman and Monteggia, 2006). Emerging studies
have indicated that BDNF plays a critical role in development
of depression and antidepressant treatment (Nawa et al., 1994;
Shimizu et al., 2003; Brunoni et al., 2008; Hammack et al., 2009;
B. H. Lee and Kim, 2010). These studies indicated that compromised hippocampal neurogenesis induced by decreased BDNF
signaling might partially contribute to the depression-like
behaviors. However, the possibe effects of CS on behaviors and
the molecular mechanism underlying the fact that early-life CS
exposures affects brain function still remains undefined.
Recent studies from Jamal’s group revealed significant associations of cigarette smoking and BDNF concentrations in serum
(Jamal et al., 2015b). Furthermore, they found that BDNF Val(66)
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Figure 1. Time line for cigarette smoke (CS) exposure and experimental measurement. Prenatal exposures occurred at gestational day (GD) 7–16; early postnatal exposure occurred at postnatal day (PND) 2–11; and late postnatal exposure occurred PND 21–30. All groups were exposed to acute restraint stress for 1 hour on PND59 and
followed by behavioral testing 24 hours later. Brain samples were harvested for all the other evaluations after the last behavioral testing.

produce significant endocrinological or behavioral changes in
naive mice. Restraint stress for a minimum 4 hours was required
to produce depression-like and anxiety-like behaviors. To test
whether CS exposure increased the vulnerability and risk of
depression-like behaviors, mice were challenged with ARS for 1
hour, and behavioral tests were performed 24 hours later.

CS Exposure
The CS exposure with the same exposure equipment and methods was used in our studies as described previously (Wu et al.,
2009, 2012). Briefly, mice were randomly placed in an exposure
chamber (BioClean, DuoFlo, model H 5500, Lab Products Inc) that
measured 1.92 x 1.92 x 0.97 m (3.58 m3). The mice were housed
in separate cages located at the exposure chamber. CS generated
from 3R4F Kentucky Reference Research Cigarettes was introduced into the exposure chamber at a rate of 4 cigarettes every
15 minutes for 6 h/d using a smoking machine (RM 1/G, Heinr
Borgwald GmbH, Hamburg, Germany). The smoking machine can
produce isolated side-stream smoke (passive tobacco smoke) or
a combination of mainstream and side-stream smoke (active
tobacco smoke). For the present study, pregnant mice were
exposed by combination of mainstream and side-stream smoke
(active tobacco smoke), and PD2 and PD21 groups were exposed
by side-stream (passive) smoke. At the end of the 6-hour exposure period, the exhaust fan on the BioClean unit was turned
on to rapidly lower the level of CS in the exposure chamber.
The mice were then transported to the animal facilities. The
concentrations of carbon monoxide in the exposure chamber
were monitored and kept at an average of about 50 parts per
million (ppm). Relative humidity was about 50% and temperature was about 23°C. Total suspended particulate concentration
was about 1.1 mg/m3. Control animals were sham exposed to FA
in whole body inhalation chambers under identical conditions
(temperature, humidity and flow rate) to CS exposed mice.

Behavioral Procedures
Before the behavioral testing, animals were habituated for 1
week by being transferred from the housing room to the testing
room, being allowed to sit for 45 minutes, gently handled, and
then returned to the housing room. The behavioral tests were

conducted in the following order 24 hours after ARS: open field
test (OFT), forced-swim test (FST), and tail-suspension test (TST)
on 3 consecutive days.
ARS
The experiment was conducted as described previously (Hare
et al., 2014). Briefly, mice were restrained in 50-mL centrifuge
tubes modified to allow air circulation for 1 hour. Mice were not
physically squeezed and not able to move forward or backward.
Mice were deprived of food and water during the entire period
of exposure to stress.
OFT
The OFT was performed as previously described (Li et al., 2009;
Masood et al., 2009). The open field was made of white acrylic
(50 × 50) with 22-cm-high walls. The floor was divided into
16 squares by black parallel and intersecting lines. Mice were
placed individually in one corner of the open-field and entry
latency (time to enter the rest of the open field from the start
location), ambulation (with all 4 paws placed into a new square),
and rearing (with both front paws raised from the floor) were
recorded for 5 minutes. The apparatus was thoroughly cleaned
using 70% ethanol after each animal.
FST
The FST was described previously (Page et al., 1999). Briefly, a
mouse was placed individually in a Plexiglas cylinder (45 cm
high × 20 cm diameter) containing water at 22 to 23°C and at
a depth of 28 cm. Immobility, which was defined as floating in
an upright position without additional activity other than necessary for the mouse to keep its head above the water, was
recorded for 6 minutes.
TST
The tail suspension test was performed as previously described
(Steru et al., 1985). Briefly, each mouse was suspended 50 cm
above the floor using adhesive tape placed approximately
1 cm from the tip of its tail. The duration of immobility was
recorded during the 6-minute test period. Mice were considered immobile only when they hung passively and completely
motionless.

Downloaded from https://academic.oup.com/ijnp/article-abstract/19/5/pyv117/2910052 by guest on 09 May 2020

\\\
GD 0

4

|

International Journal of Neuropsychopharmacology, 2016

Gene Expression of Neurotrophins and Receptors

Enzyme-Linked Immunosorbent Assay (ELISA)

Mice were sacrificed by decapitation after the last behavioral
test. The hippocampus and prefrontal cortex were dissected
and immediately frozen on dry ice and kept at -80°C. To determine neurotrophins and their receptors, RNA was extracted
using TRIzol reagent (Invitrogen), and a portion (2 μg) of total
RNA isolated was treated with Turbo DNase (Turbo DNA-free
kit; Ambion) and reverse-transcribed into cDNA with the use
of the RT2 first strand kit (Qiagen Inc, Valencia, CA) following the manufacturer’s instructions. Mouse neurotrophin and
receptors RT2 Profiler PCR Array kit (Qiagen Inc) was selected
for the present study. PCR Array was performed according to
the manufacturer’s protocol. Briefly, an experimental cocktail was prepared for each plate made up of the processed
cDNA and 2× instrument-specific and ready-to-use array RT2
qPCR master mix, containing SYBR Green and a reference dye.
A portion (25 μL) of the experimental cocktail was placed into
each well of the PCR array plate containing the predispensed
gene-specific primer sets, and PCR was performed on the ABI
Prism 7500 Sequence Detection System. A 2-step cycling program was used (10 minutes at 95°C to activate the HotStart
DNA polymerase, followed by 40 cycles of denaturing for 15
seconds at 95°C and annealing for 1 minute at 60°C). Data
collected was entered into online software PCR Array Data
Analysis Web Portal provided by the manufacturer for data
analysis. Gene expression levels were normalized against
the housekeeping genes, including GUSB (glucuronidase β),
HPRT1 (hypoxanthine guanine phosphoribosyl transferase 1),
HSP90AB1 (heat-shock protein α class B member 1), GAPDH,
and ACTB (β-actin). Fold changes in gene expression were
calculated using the 2−ΔΔCt method using the manufacturer’s
software.

Hippocampus and prefrontal cortex were homogenized in icecold lysis buffer (Upstate,Temecula, CA) and then centrifuged
at 16 000 × g for 20 minutes (4°C). The supernatants were subsequently analyzed by ELISA for BDNF (Promega, Madison, WI)
according to the manufacturer’s instructions. All samples were
run in triplicate, and as a negative control, a Phosphate-buffered
saline sample was run with each assay.

The hippocampus and prefrontal cortex were homogenized
in ice-cold RIPA lysis buffer (Upstate, Temecula, CA) and centrifuged at 16 000 × g for 30 minutes. Supernatant was mixed
with an equal volume of Laemmli sample buffer and heated
to 100°C for 2 minutes. Variable volumes of sample containing equal amounts of protein were loaded onto gels for SDSPAGE. Following separation by electrophoresis, proteins in
the gels were transferred to nitrocellulose membranes, which
were incubated with rabbit phospho-TrkB antibody (1:500;
Santa Cruz, Dallas,Tx) or β-actin antibodies (1:1000; Chemicon,
Temecula, CA) overnight at 4°C and then with Alexa Fluor
680-conjugated secondary antibody (1:20 000; Invitrogen) for 30
minutes at room temperature. The detection and quantification
of specific bands were carried out using a fluorescence scanner (Odyssey Infrared Imaging System, LI-COR Biotechnology,
Lincoln, NE).

Unless otherwise stated, results are expressed as mean ± SEM.
Statistical analyses of behavioral test, ELISA, and Western
blotting were performed using 2-way ANOVA followed by
Bonferroni’s posthoc test. One factor is age, and another factor is CS exposure. The data of PCR array were calculated using
the 2−ΔΔCt method using the manufacturer’s software. P < .05 was
considered significant, and n represents the number of animals
studied.

Results
Effect of the Prenatal and Postnatal CS Exposure on
Depression-Like Behaviors
The level of serum cotinine was monitored at GD 7, GD 10, and
GD 15 in GD7 group from dams, PND 3, PND 6, and PND 10 in
PND2 group from pups, and PND 22, PND 25, and PND 29 in
PND21 group (Table 1).
Before the experiment on PND 59, the weights (mean ± SEM)
of CS exposure in GD7 (25.5 ± 1.2 g, n = 9), PND2 (26.1 ± 1.1 g, n = 9),
and PND21 (26.4 ± 1.4 g, n = 9) were not significantly different from
corresponding FA control groups (GD7: 26.6 ± 1.2 g, n = 9, t = 0.779,
P = .436; PND2: 27.1 ± 1.4 g, n = 9, t = 0.597, P = .559 and PND2:
27.2 ± 1.3 g, n = 9, t = 0.523, P = .608, respectively) (Figure 2A).
In the OFT, there was no significant difference in ambulation between the FA and CS exposure groups at any time period
(GD7, PND2, or PND21) (Figure 2B). However, the prenatal and
early postnatal (GD7 and PND2), but not PND21 CS exposure, significantly increased entry latency by 70.61% (t = 5.66, P < .001)
and 75.13% (t = 5.24, P < .001), respectively, compared with their
FA exposure groups (Figure 1C). Only GD7 CS exposure induced a
decrease by 38.93% in rearing (t = 7.36, P < .001). In contrast, both
PND2 and PND21 CS exposure did not result in any changes in
numbers of rearing (Figure 2D).
In the FST, immobility of GD7 and PND2 CS exposure groups
was significantly increased by 108.69% (t = 7.28, P < .001) and
79.72% (t = 4.69, P = .024) respectively compared with their FA
exposure. By contrast, immobility was not changed significantly
by CS exposure in the PND21 groups (Figure 3A). A similar pattern
of changes was also found in the TST (Figure 3B). Immobility was

Table 1. The Levels of Cotinine (ng/mL) at Different Times during CS or FA Exposure
First Monitoring

GD7
PND2
PND21

Second Monitoring

Third Monitoring

CS

FA

CS

FA

CS

FA

46.01 ± 5.18
50.98 ± 5.14
48.01 ± 6.30

0.21 ± 0.08
0.20 ± 0.09
0.19 ± 0.08

49.99 ± 6.08
51.97 ± 6.69
49.99 ± 6.08

0.19 ± 0.09
0.22 ± 0.08
0.19 ± 0.09

51.98 ± 5.13
52.96 ± 6.53
55.44 ± 6.21

0.20 ± 0.08
0.20 ± 0.09
0.22 ± 0.09

Data are means ± SEM. n= 5 mice samples/monitoring/group.
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Effect of the Prenatal and Postnatal CS Exposure on
mRNA Levels of Neurotrophins and Receptors
The gene expressions of neurotrophins and their receptors
in the hippocampus and prefrontal cortex were tested using
RT2 Profiler PCR Array. As shown in Figure 4A and D, CS exposure in the GD7 group significantly decreased BDNF mRNA
by 79% (P = .021) and 68% (P = .024) respectively in the hippocampus and prefrontal cortex compared with their FA controls. In addition, TrkB mRNA was increased by 186% (P = .001)
and 98% (P = .006) in the hippocampus and prefrontal cortex,
respectively, in comparison with FA exposure groups. In PND2
group, CS exposure also induced a significant decrease in BDNF
mRNA by 48% (P = .038) and an increase in TrkB mRNA by 132%
(P = .003) by compensation in the hippocampus. However, no
similar changes in either BDNF mRNA or TrkB mRNA were
found in prefrontal cortex (Figure 4B,E). In the PND21 group,
CS exposure did not produce any significant changes in mRNA
levels of any neurotrophins and their receptors (Figure 4C,F).
Other genes analyzed in GD7, PND2, and PND21, which included
nerve growth factor, neurotrophin-3, neurotrophin-4, and neurotrophic tyrosine kinase receptor A, did not demonstrate any
significant changes in CS exposure groups in comparison with
FA control groups.

Figure 3. Effects of the prenatal and postnatal cigarette smoke (CS) exposure
on immobility in forced-swim test (FST) (A) and tail suspension test (TST) (B).
Immobility in gestational day (GD)7 CS exposure groups was increased in both
TST and FST, indicating depression-like behaviors. Data shown represent means
± SEM; n = 9/group. *P ≤ 0.05, **P < .01 Significant difference comparing corresponding data between filtered air (FA) and CS groups.

significantly increased by 89.36% in the GD7 CS exposure group
in comparison with FA control (t = 7.28, P < .001). However, PND2
CS exposure only increased immobility by 41.79% compared
with FA exposure control, but not significantly (t = 3.01, P = .061).
In addition, no significant differences were found in PND21 CS
exposure groups compared with FA control. These findings suggest that the initial exposure to CS during the prenatal or early
postnatal period significantly enhanced depression-like behaviors in offspring.

Effect of the Prenatal or Postnatal CS Exposure on
BDNF Protein Levels
To measure whether CS exposure influences protein level, BDNF
in the hippocampus and prefrontal cortex was measured by
ELISA. Data showed that BDNF protein level was significantly
decreased in the GD7 CS exposure group by 55.08% (t = 4.52,
P = .022) (Figure 5A) and 61.26% (t=5.02, P = .013) (Figure 5B) in the
hippocampus and prefrontal cortex, respectively, compared with
FA controls. Similarly, PND2 CS exposure also induced a trend of
reduction in BDNF protein level in hippocampus and prefrontal
cortex by 32.31% (t = 3.22, P = .063) and 27.79% (t = 2.69, P = .072)
(Figure 5A-B), but not statistically significant. By contrast, PND21
CS exposure did not induce any significant changes in the protein level of BDNF compared with FA control.
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Figure 2. Effects of the prenatal and postnatal cigarette smoke (CS) exposure on weight (A), ambulation (B), latency (C), and rearing (D) in the open field test (OFT). Data
shown represent means ± SEM; n = 9/group. *P < .05, **P < .01, Significant difference comparing corresponding data between filtered air (FA) and CS animals.
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Effect of the Prenatal or Postnatal CS Exposure on
Levels of Phosphorylated TrkB
To determine whether the activation of TrkB receptor is altered as the
downstream target of BDNF signaling, phosphorylated TrkB in hippocampus and prefrontal cortex were studied. The results showed
that the level of phosphorylated TrkB was significantly decreased
by 47.02% (t = 7.69, P = .029) in the hippocampus (Figure 6A) and
by 42.72% (t = 6.67, P = .031) in prefrontal cortex (Figure 6B) in GD7
CS exposure group compared with control. PND2 CS exposure
only induced a trend of decrease in phosphorylated TrkB by 26.8%
(t = 3.28, P = .059) in hippocampus and by 15.3% (t = 2.77, P = .074)
in prefrontal cortex respectively. In contrast to the GD7 and PND2
groups, PND21 CS exposure did not induce any significant changes
in either hippocampus or prefrontal cortex (Figure 6A-B).

Discussion
Recent studies have shown that maternal smoking during pregnancy and childhood secondhand smoke may increase risk for

depression in later life (Herrmann et al., 2008; Cornelius et al., 2011;
Mbah et al., 2013; Elmasry et al., 2014; Holz et al., 2014; Yochum
et al., 2014). Epidemiological studies also found that children are
more susceptible to adverse behavioral effects of passive smoking than adults (Herrmann et al., 2008; Cornelius et al., 2011; Holz
et al., 2014), suggesting that exposure to environmental tobacco
smoke in early life might be a predisposing factor for such conditions. The results obtained from the current study showed that
the changes of behaviors were significantly different between
the GD7 CS exposure and control groups, and the levels of BDNF
and phosphorylated TrkB in hippocampus were significantly
decreased in mice initially exposed to CS during early periods of
development (prenatal and early postnatal period). However, initial exposure to CS during a late period of development (PND21)
did not appear to affect depression-like behaviors and BDNF/TrkB
in hippocampus, suggesting that a critical period of susceptibility
exists during prenatal and early postnatal periods.
During the prenatal and early postnatal stage of life, the
central nervous system is not fully developed. The sensitivity
of the central nervous system in newborns is higher than in
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Figure 4. Effects of the prenatal and postnatal cigarette smoke (CS) exposure on gene expression of neurotrophins and their receptors in the hippocampus (A-C) and
prefrontal cortex (D-F). Neurotrophins and their receptors including nerve growth factor, brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4, low-affinity nerve growth factor receptor P75, neurotrophic tyrosine kinase receptor A (TrkA), and neurotrophic tyrosine kinase receptor B (TrkB) were measured
by RT2 Profiler PCR Array. Data shown represent means ± SEM; n = 6/group. *P ≤ .05, **P < .01 vs filtered air (FA) exposure.
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adults (Larsen, 1993). This might be due to the level of BDNF in
brain during the early development period. BDNF is lowest during the embryo period and then gradually increases into adulthood, especially in the hippocampus (Maisonpierre et al., 1990),
which is consistent with the timing of robust neurogenesis in
the central nervous system (Altman and Bayer, 1984; Lehuen
et al., 1990). Throughout the development of the central nervous system, BDNF is responsible for proliferation and maintenance via regulating neuronal plasticity, influencing neuronal

differentiation, and survival (Soule et al., 2006; Cowansage et al.,
2010). Mice lacking BDNF demonstrated severe deficiencies in
central nervous system development (Ernfors et al., 1994; PozzoMiller et al., 1999). Thus, dysregulated BDNF level by CS exposure during the critical period of rapid brain growth may alter
the normal developmental process and lead to long-term cellular alterations that result in the inability of the brain to make
appropriate adaptive responses (Cornelius and Day, 2009) and
contribute to the depression-like behaviors in later life.
Previous studies have reported that mice with deficiency in
BDNF demonstrated depression-like behaviors, and administration of BDNF produced antidepressant effects (Nawa et al.,
1994; Karege et al., 2002; Shimizu et al., 2003; Karege et al., 2005;
Brunoni et al., 2008; Hammack et al., 2009; B. H. Lee and Kim,
2010), indicating BDNF correlates with development of depression. In addition, plasma level of BDNF in patients with major
depression was significantly lower than healthy participants
(Gonul et al., 2005; Karege et al., 2005; Brunoni et al., 2008), and
chronic antidepressant treatment significantly relieved the
clinical symptoms by increasing BDNF (Shimizu et al., 2003) and
activation of TrkB in the brain (Castren et al., 2007; Monteggia
et al., 2007; B. H. Lee and Kim, 2010). These findings are consistent with our finding that prenatal and early postnatal (GD7 and
PND2) CS exposure decreased BDNF level and TrkB activation
and increased depression-like behaviors. However, other studies have shown that deficiency of BDNF or TrkB cannot induce
depressed behaviors, although BDNF is required for effective
antidepressant treatment and recovery of neuronal networks
(Nawa et al., 1994; Pozzo-Miller et al., 1999; Saarelainen et al.,
2003; B. H. Lee and Kim, 2010; Papaleo et al., 2011). Therefore,
further studies are needed to investigate whether BDNF or
TrkB receptor agonist can reverse abnormal neuronal networks
and behavioral changes induced by CS exposure. Recent studies found that glial cell derived neurotrophic factor promoted
development of neurons and played an important role in the
pathogenesis of mood disorders (Barbosa et al., 2011; Tunca
et al., 2014, 2015). It is not clear whether it functions simultaneously as BDNF via same mechanism in CS exposure-induced
abnormalities during early life and needs further investigation
in the future.
Structural and morphological abnormalities in specific
brain regions such as prefrontal cortex and hippocampus are

Figure 6. Effects of the prenatal and postnatal cigarette smoke (CS) exposure on phosphorylated neurotrophic tyrosine kinase receptor B (TrkB) in hippocampus (A)
and prefrontal cortex (B). Phosphorylated TrkB was significantly decreased in GD7 CS exposure group in comparison with filtered air (FA) control in both hippocampus
and prefrontal cortex. Data shown represent means ± SEM; n = 6/group. *P ≤ .05, **P < .01 vs FA exposure.
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Figure 5. Effects of the prenatal and postnatal cigarette smoke (CS) exposure on
protein level of brain derived neurotrophic factor (BDNF) in the hippocampus
and prefrontal cortex. Gestation day (GD)7 CS exposure significantly decreased
BDNF protein level in both hippocampus (A) and prefrontal cortex (B). Data
shown represent means ± SEM; n = 6/group. *P ≤ .05, **P < .01 vs filtered air (FA)
exposure.
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Previous studies have found that significant strain differences
exist for variables used to measure depression-like behaviors in
mice models such as FST and TST (Lucki et al., 2001; Mineur et al.,
2006; Sade et al., 2014). C57BL/6 mice demonstrate a decrease in
immobility in TST, whereas BALB/C mice show an increase in
immobility after chronic mild stress (Mineur et al., 2006). A study
comparing 11 mouse strains in the FST showed that there is a
10-fold range of immobility values (Lucki et al., 2001). These suggest the existence of substantial behavioral differences between
mouse strains in the baseline performance. ICR mouse is a wellestablished animal model that has been used extensively for
studying behavioral profiles (Sade et al., 2014; Avitsur et al., 2015;
Yokota et al., 2015). Recent studies showed that prenatal exposure to diesel exhaust particles and fluoxetine affects behavioral response in ICR mice (Avitsur et al., 2015; Yokota et al., 2015).
Thus, ICR mice were used in our behavioral studies. In addition,
gender differences exist in the etiology and responses to stress
in mice (Palanza, 2001; Frye and Walf, 2009). Emerging evidence
has demonstrated that antidepressant-induced behavioral
effects vary with the estrous cycle in female animals (Carrier and
Kabbaj, 2013; Franceschelli et al., 2015), indicating that gonadal
hormones can at least partially contribute to the differences
of responses to antidepressant treatment between male and
female rodents. To avoid the influence of gonadal hormones to
our experiment, male ICR were used in our study.
In conclusion, the results showed that exposure to CS during
prenatal (maternal exposure) and early postnatal life increased
the depression-like behaviors and decreased BDNF/TrkB signaling later in life. Interestingly, these responses were not observed
when CS exposure occurred in late postnatal life (near puberty
in mice), suggesting that a critical period of susceptibility to
CS exposure exists in the prenatal and early postnatal period
of brain development in mice, which results in a downregulation in BDNF/TrkB signaling in the hippocampus and enhances
depression-like behaviors later in life.
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